基于RNA的治疗机会,用于治疗脏疾病
Jurriën Prins1, Annabelle Biscans2, Anton Jan van Zonneveld3,4
1Vico Therapeutics, Leiden, the Netherlands.
Nature reviews. Nephrology
|October 9, 2025
概括
对于许多疾病来说,RNA疗法是有前途的,但脏应用面临着挑战. 需要新的策略来改善药物输送和治疗脏疾病的疗效,使用基于RNA的疗法.
科学领域:
- 生物技术是生物技术.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于RNA的疗法已经取得了重大进展,可以治疗各种疾病.
- 了解细胞类型和转录组推动了治疗的发展.
- 脏疾病仍然是RNA疗法的挑战,原因是药物输送和疗效差.
研究的目的:
- 审查基于RNA治疗脏疾病的挑战和潜力.
- 强调需要改进向脏的RNA药物输送和细胞吸收的战略.
- 探索当前和未来的RNA治疗方法用于病理.
主要方法:
- 基于RNA的治疗策略的文献综述.
- 对RNA药物输送到脏的挑战进行分析.
- 探索细胞向和吸收增强技术.
主要成果:
- 在病治疗中,RNA疗法面临着重大障碍,包括快速分泌,非位局部化和内分泌体捕获.
- 目前的RNA治疗方式,如拼接调节器,小干扰RNA和体,在脏应用中表现出有限的成功.
- 改善细胞类型向和生产性RNA药物吸收的策略对于治疗进步至关重要.
结论:
- 尽管面临挑战,但基于RNA的疗法对脏疾病具有前景.
- 向的输送和增强的细胞吸收对于成功的RNA疗法在病学中至关重要.
- 需要进一步的研究和验证,以克服目前的局限性,并实现基于RNA治疗脏疾病的潜力.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
Kidney Transplant I: Introduction
340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Chronic Kidney Disease I: Introduction
560
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
560
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932


